Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Datasets
Activities
Prizes
Search by expertise, name or affiliation
Therapeutic angiogenesis for critical limb ischemia: Design of the hepatocyte growth factor therapeutic angiogenesis clinical trial
Richard J. Powell
, John Dormandy
, Michael Simons
, Ryuichi Morishita
,
Brian H. Annex
Research output
:
Contribution to journal
›
Article
›
peer-review
34
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutic angiogenesis for critical limb ischemia: Design of the hepatocyte growth factor therapeutic angiogenesis clinical trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Trials
100%
Hepatocyte Growth Factor
100%
Therapeutic Angiogenesis
100%
Critical Limb Ischemia
100%
Plasmid DNA (pDNA)
33%
Placebo
16%
Gene Transfer
16%
Perfusion
16%
Dose-response
16%
Impaired Quality of Life
16%
Placebo-controlled
16%
Dosing Regimen
16%
Therapeutic Strategies
16%
Tissue Perfusion
16%
Percutaneous Intervention
16%
Current Therapeutics
16%
TcPO2
16%
Bypass Surgery
16%
Investigational Method
16%
Limb Loss
16%
Transcutaneous Oxygen
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Scatter Factor
100%
Critical Limb Ischemia
100%
Placebo
33%
Plasmid DNA
33%
Sodium Chloride
16%